Up to 480 March for Science rallies are scheduled to take place on Earth Day, April 22 in almost 500 cities in at least 37 countries, according to the movement's organizers.
Enrolling less homogeneous patient groups in clinical trials while maintaining safety may lead to a more accurate description of a drug's safety and efficacy, FDA officials wrote in an article published April 20 in the New England Journal of Medicine.
When the University of Utah officials unexpectedly fired Mary Beckerle from her job as CEO and director of the Huntsman Cancer Institute earlier this week, they made an enemy few people in the state would wish for: the powerful Huntsman family.
Jon Huntsman, Sr., said he was shocked by the unexpected firing of Mary Beckerle, CEO and director of the cancer center he founded and which his family continues to fund.
On Monday, April 17, Mary Beckerle opened her email and learned that she is no longer the CEO and director of the University of Utah's Huntsman Cancer Institute.
FDA has removed the Risk Evaluation and Mitigation Strategy requirements for erythropoiesis-stimulating agents in patients with anemia due to associated myelo-suppressive chemotherapy.
The Human Vaccines Project, Vanderbilt University Medical Center and Illumina Inc. are collaborating on a project focused on deciphering the human immunome, the genetic underpinnings of the immune system.
Ronald DeMatteo was appointed chair of the Department of Surgery in the Perelman School of Medicine at the University of Pennsylvania, effective July 1.
Ahmad Samer Al-Homsi will lead a new bone marrow transplantation program at the NYU Langone Perlmutter Cancer Center for treating blood-borne cancers, and potentially utilize transplantation as an adjunct to immunotherapy for solid tumors.
Ophira Ginsburg has joined NYU Langone's Perlmutter Cancer Center as director of its new High Risk Program, which identifies, studies and cares for patients with hereditary syndromes that increase cancer risk.
